Ditchcarbon
  • Contact
  1. Organizations
  2. Yuhan Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
KR
updated a month ago

Yuhan Corporation Sustainability Profile

Company website

Yuhan Corporation, a leading pharmaceutical company based in South Korea (KR), has been at the forefront of the industry since its establishment in 1926. With its headquarters in Seoul, Yuhan operates extensively across Asia, Europe, and North America, focusing on innovative drug development and manufacturing. Specialising in prescription pharmaceuticals, over-the-counter products, and biopharmaceuticals, Yuhan is renowned for its commitment to research and development, which has led to significant advancements in oncology, cardiology, and infectious diseases. The company has achieved notable milestones, including strategic partnerships and a robust pipeline of new therapies, solidifying its position as a key player in the global market. Yuhan Corporation's dedication to quality and innovation continues to drive its success, making it a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Yuhan Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Yuhan Corporation's score of 35 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

56%

Let us know if this data was useful to you

Yuhan Corporation's reported carbon emissions

In 2023, Yuhan Corporation reported total carbon emissions of approximately 7,756,000 kg CO2e for Scope 1 and about 16,818,000 kg CO2e for Scope 2, resulting in a combined total of around 24,564,000 kg CO2e for both scopes. This marks a slight decrease from 2022, where emissions were approximately 7,819,000 kg CO2e for Scope 1 and about 16,191,000 kg CO2e for Scope 2, totalling around 24,000,000 kg CO2e. In 2021, the company recorded emissions of about 7,492,000 kg CO2e for Scope 1 and approximately 15,246,000 kg CO2e for Scope 2, leading to a total of around 22,724,000 kg CO2e. Yuhan Corporation has committed to achieving net-zero greenhouse gas emissions by 2050, as part of its long-term climate strategy initiated in 2023. This commitment reflects the company's recognition of the urgent need for global cooperation in addressing climate change. Currently, Yuhan has not disclosed any Scope 3 emissions data, nor does it have specific Science-Based Targets Initiative (SBTi) targets. Overall, Yuhan Corporation is actively working towards reducing its carbon footprint while aiming for significant long-term sustainability goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
7,492,000
0,000,000
0,000,000
Scope 2
15,246,000
00,000,000
00,000,000
Scope 3
-
-
-

How Carbon Intensive is Yuhan Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Yuhan Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Yuhan Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Yuhan Corporation is in KR, which we do not have grid emissions data for.

Yuhan Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Yuhan Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Yuhan Corporation's Emissions with Industry Peers

Zai Lab

CN
•
Pharmaceutical Preparation Manufacturing
Updated about 17 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 25 minutes ago

Lg Chem

KR
•
Chemicals nec
Updated 10 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Novimmune SA

CH
•
Research and development services (73)
Updated 16 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy